209 related articles for article (PubMed ID: 21447170)
1. No evidence of XMRV in prostate cancer cohorts in the Midwestern United States.
Sakuma T; Hué S; Squillace KA; Tonne JM; Blackburn PR; Ohmine S; Thatava T; Towers GJ; Ikeda Y
Retrovirology; 2011 Mar; 8():23. PubMed ID: 21447170
[TBL] [Abstract][Full Text] [Related]
2. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences.
Oakes B; Tai AK; Cingöz O; Henefield MH; Levine S; Coffin JM; Huber BT
Retrovirology; 2010 Dec; 7():109. PubMed ID: 21171973
[TBL] [Abstract][Full Text] [Related]
3. No association between XMRV or related gammaretroviruses in Australian prostate cancer patients.
Rezaei SD; Hearps AC; Mills J; Pedersen J; Tachedjian G
Virol J; 2013 Jan; 10():20. PubMed ID: 23305518
[TBL] [Abstract][Full Text] [Related]
4. No association of xenotropic murine leukemia virus-related viruses with prostate cancer.
Switzer WM; Jia H; Zheng H; Tang S; Heneine W
PLoS One; 2011 May; 6(5):e19065. PubMed ID: 21573232
[TBL] [Abstract][Full Text] [Related]
5. No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
Stieler K; Schindler S; Schlomm T; Hohn O; Bannert N; Simon R; Minner S; Schindler M; Fischer N
PLoS One; 2011; 6(10):e25592. PubMed ID: 22022417
[TBL] [Abstract][Full Text] [Related]
6. Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions.
Danielson BP; Ayala GE; Kimata JT
J Infect Dis; 2010 Nov; 202(10):1470-7. PubMed ID: 20936978
[TBL] [Abstract][Full Text] [Related]
7. Disease-associated XMRV sequences are consistent with laboratory contamination.
Hué S; Gray ER; Gall A; Katzourakis A; Tan CP; Houldcroft CJ; McLaren S; Pillay D; Futreal A; Garson JA; Pybus OG; Kellam P; Towers GJ
Retrovirology; 2010 Dec; 7(1):111. PubMed ID: 21171979
[TBL] [Abstract][Full Text] [Related]
8. No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan.
Furuta RA; Miyazawa T; Sugiyama T; Kuratsune H; Ikeda Y; Sato E; Misawa N; Nakatomi Y; Sakuma R; Yasui K; Yamaguti K; Hirayama F
Retrovirology; 2011 Mar; 8():20. PubMed ID: 21414229
[TBL] [Abstract][Full Text] [Related]
9. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.
Lee D; Das Gupta J; Gaughan C; Steffen I; Tang N; Luk KC; Qiu X; Urisman A; Fischer N; Molinaro R; Broz M; Schochetman G; Klein EA; Ganem D; Derisi JL; Simmons G; Hackett J; Silverman RH; Chiu CY
PLoS One; 2012; 7(9):e44954. PubMed ID: 23028701
[TBL] [Abstract][Full Text] [Related]
10. Lack of evidence for a role of xenotropic murine leukemia virus-related virus in the pathogenesis of prostate cancer and/or chronic fatigue syndrome.
Hong P; Li J
Virus Res; 2012 Jul; 167(1):1-7. PubMed ID: 22531412
[TBL] [Abstract][Full Text] [Related]
11. Mouse DNA contamination in human tissue tested for XMRV.
Robinson MJ; Erlwein OW; Kaye S; Weber J; Cingoz O; Patel A; Walker MM; Kim WJ; Uiprasertkul M; Coffin JM; McClure MO
Retrovirology; 2010 Dec; 7():108. PubMed ID: 21171966
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients.
Hohn O; Krause H; Barbarotto P; Niederstadt L; Beimforde N; Denner J; Miller K; Kurth R; Bannert N
Retrovirology; 2009 Oct; 6():92. PubMed ID: 19835577
[TBL] [Abstract][Full Text] [Related]
13. XMRV: a new virus in prostate cancer?
Aloia AL; Sfanos KS; Isaacs WB; Zheng Q; Maldarelli F; De Marzo AM; Rein A
Cancer Res; 2010 Dec; 70(24):10028-33. PubMed ID: 20966126
[TBL] [Abstract][Full Text] [Related]
14. Xenotropic murine leukemia virus-related virus is not associated with chronic fatigue syndrome in patients from different areas of the us in the 1990s.
Ali MA; Dale JK; Kozak CA; Goldbach-Mansky R; Miller FW; Straus SE; Cohen JI
Virol J; 2011 Sep; 8():450. PubMed ID: 21943244
[TBL] [Abstract][Full Text] [Related]
15. An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV.
Sato E; Furuta RA; Miyazawa T
Retrovirology; 2010 Dec; 7():110. PubMed ID: 21171978
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.
Arredondo M; Hackett J; de Bethencourt FR; Treviño A; Escudero D; Collado A; Qiu X; Swanson P; Soriano V; de Mendoza C
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1089-94. PubMed ID: 22206583
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of xenotropic murine leukemia virus and its R426Q polymorphism in patients with prostate cancer in Kerman, southeast of Iran.
Reza MA; Fahimeh G; Reza MH
Asian Pac J Cancer Prev; 2012; 13(8):3669-73. PubMed ID: 23098452
[TBL] [Abstract][Full Text] [Related]
18. No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients.
Mendoza R; Silverman RH; Klein EA; Miller AD
PLoS One; 2012; 7(5):e36073. PubMed ID: 22615749
[TBL] [Abstract][Full Text] [Related]
19. Multiple sources of contamination in samples from patients reported to have XMRV infection.
Kearney MF; Spindler J; Wiegand A; Shao W; Anderson EM; Maldarelli F; Ruscetti FW; Mellors JW; Hughes SH; Le Grice SF; Coffin JM
PLoS One; 2012; 7(2):e30889. PubMed ID: 22363509
[TBL] [Abstract][Full Text] [Related]
20. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.
Schlaberg R; Choe DJ; Brown KR; Thaker HM; Singh IR
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16351-6. PubMed ID: 19805305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
